I. Alekseeva

Evaluation of in vitro activity of ceftolozane/tazobactam and comparators against recent clinical bacterial isolates, and genomics of Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli isolates that demonstrated resistance to ceftolozane/tazobactam: data from Kuwait and Oman

A. Mustafa, E. Mokaddas, W. Alfouzan, 2022, JAC-antimicrobial resistance.

Activity of Ceftolozane/Tazobactam Against Clinical Isolates of Pseudomonas aeruginosa from Patients in the Middle East and Africa - SMART 2017-2020.

M. Motyl, D. Sahm, K. Young, 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Clinical case of Bloch — Sulzberger syndrome

T. Chernova, I. Alekseeva, N. V. Krasnova, 2020 .

[AntiEBV activity of 6-azacytidine and its derivatives].

A. Golovan, I. Alekseeva, N. V. Nesterova, 2011, Mikrobiolohichnyi zhurnal.

Changes in blood chemistry values of the cattle with associative course of leukemia and brucellosis

I. Alekseeva, V. Pleshakova, V. Vlasenko, 2020, BIO Web of Conferences.

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020

M. Motyl, D. Sahm, S. Hawser, 2023, European Journal of Clinical Microbiology & Infectious Diseases.

Collective assessment of antimicrobial susceptibility among the most common Gram-negative respiratory pathogens driving therapy in the ICU

M. Hackel, M. Motyl, P. Moise, 2021, JAC-antimicrobial resistance.

[Development of acute myeloid leukemia from donor cells after allogeneic peripheral blood stem cell transplantation in a female patient with acute monoblastic leukemia].

I. V. Alekseeva, I. Demidova, E. Parovichnikova, 2011, Terapevticheskii arkhiv.